The major alternative payment model put forth by Medicare, the Oncology Care Model, doesn’t tell practices how they are doing until after the fact. This puts practices at risk for things beyond their control, said Barbara McAneny, MD, a New Mexico oncologist/hematologist who is the current president of the American Medical Association (AMA).
America's healthcare system costs too much, not just for patients who become ill but also for medical students who must pay for their own training and oncology practices trying to navigate payment models that ask them to take on risk associated with the eye-popping costs of cancer drugs.
The major alternative payment model (APM) put forth by Medicare, the Oncology Care Model (OCM),1 doesn’t tell practices how they are doing until after the fact. This puts practices at risk for things beyond their control, said Barbara McAneny, MD, a New Mexico oncologist/hematologist who is the current president of the American Medical Association (AMA).2
McAneny shared her diagnosis for the current crisis in US healthcare, as well as a prescription—a new real-time oncology payment model led by physicians—in her keynote address to attendees at Patient-Centered Oncology Care® (PCOC) 2018, the annual meeting presented by The American Journal of Managed Care®, which took place November 16, 2018, at Sofitel Philadelphia, in Pennsylvania.
Healthcare has reached a crisis point because payers are controlling the process and doctors are being driven away by administrative burdens and burnout, McAneny said. Medical education is extremely expensive, and young doctors enter professional life burdened with $200,000 or more in debt that limits their options. “We can’t afford to train someone for 10 to 12 years and then drive them crazy so they quit,” she said.
Yet, that’s what’s happening to so many physicians, and it’s contributing to physician shortages. “It used to be we had to push doctors out the door at age 70,” McAneny said. Now, too many get into their 50s and have had enough of the documentation burdens that today’s electronic health systems demand. As PCOC Chairman Joseph Alvarnas, MD, of City of Hope, would ask later in the day, “How do we get to a future that isn’t built on people working until midnight?”
McAneny became well known for developing the COME HOME model at her New Mexico practice,3 which saved $2100 annually per patient by prioritizing triage protocols, clinical pathways, same-day appointments, and better patient education—all with the goal of keeping patients out of the emergency department and avoiding hospital stays. “We created savings through the things that the doctors can control,” she said.
The OCM does much of this, but it adds features McAneny does not like. Although the model keeps people out of the hospital, it adds documentation that she finds burdensome.
“My [electronic medical record] is really good at managing patients one at a time,” but it is not as good at population health, she said.
But the bigger challenge is the way the model handles drug costs. McAneny said Medicare “lowballs” these costs, and the Indian Health Service, which covers many of her patients, is even worse.
Oncologists are put in the position of taking on risk and becoming miniature insurers, when they don’t have actuaries or reserves to predict who will come through the door, much less to absorb losses. As a result, more and more independent physician practices are being bought up by hospitals, which doubles the cost of care.
And who is making money? McAneny showed a slide that reported Anthem Blue Cross and Blue Shield reporting a record profit.4
“Everybody is familiar with these stories, with what’s going on in oncology with the site-of-service differential,” she said, referring to reimbursements for care at a hospital versus a community oncology clinic. “It has to change. This cannot go on.”
If nothing changes, McAneny said, healthcare costs will crowd out everything else in the federal budget, and that will not be acceptable or sustainable. She pointed out incongruities in federal policy that will pay to amputate a foot for someone with diabetes but bankrupt a person who needed insulin that could have prevented that complication.
“What patients want is not healthcare, but health,” she said.
The AMA is pushing for changes that give physicians more control over healthcare, from rethinking medical education to putting doctors at the center of healthcare delivery. To that end, McAneny noted that CMS’ emphasis on the Medicare Shared Savings Program (MSSP), delivered through accountable care organizations, has never quite achieved what she managed to do with COME HOME.
Instead of $2100 in savings per patient, MSSP puts physicians through enormous expense and incon- venience to achieve $313.7 million in savings for CMS. “That’s a lot if you won the lottery but not if you’re running Medicare—$36 per patient is 1 office visit,” McAneny said.
In cancer care, McAneny and a coalition of oncology practices, called the National Cancer Care Alliance, have stepped forward with a different APM called MASON (Making Accountable Sustainable Oncology Networks),5 which seeks to create real-time quality measurement so that practices can respond to outliers and problems right away, not months or years after the fact.
The model “creates an accurate cost target that will be a valuable tool for optimizing patient manage- ment while avoiding actuarial risks of adverse patient clinical characteristics,” the proposal states. “Practices will be at risk only for factors they can control, thereby avoiding damage to the oncology care delivery infrastructure across the country.” The model will incorporate the multiple data points that bombard physicians today and allow for personalization based on patient characteristics.
At the time of PCOC, McAneny was preparing to present the model to the Physician-Focused Payment Model Technical Advisory Committee (PTAC), which is empowered to approve doctor-driven payment models. On December 11, 2018, PTAC approved MASON by a 7-0 vote.6 But thus far, CMS has not approved any APMs that have been through PTAC.
If MASON succeeds, it will be a step toward letting physicians return to their core mission, McAneny said. “We need doctors and hospitals to take care of patients.”REFERENCES:
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
FDA Approves Danziten for Chronic Myeloid Leukemia Without Mealtime Restrictions
November 14th 2024The FDA has granted approval to Azurity Pharmaceuticals' nilotinib tablets (Danziten), a novel version of the tyrosine kinase inhibitor for chronic myeloid leukemia that can be taken without mealtime restrictions.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More